|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.42 USD | +1.62% |
|
+4.54% | +18.32% |
| Apr. 11 | Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes | MT |
| Feb. 26 | Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating | MT |
Collegium Pharmaceutical, Inc. provided earnings guidance for the year 2024. For the year, the company expects net product revenues to be in the range of $580.0 million to $595.0 million.
| 1st Jan change | Capi. | |
|---|---|---|
| +18.32% | 1.19B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
COLLEGIUM PHARMACEUTICAL, INC. 
